On April 26, 2023, ETAO International Co., Ltd. (NASDAQ: ETAO) experienced a staggering 42% surge in its share price at the market open. However, obtaining information...
Virios Therapeutics (NASDAQ: VIRI) shares are soaring on Tuesday after a promising update on its Phase 3 clinical trial of IMC-1, the company’s leading drug candidate...
IN8bio, Inc (NASDAQ: INAB) just released very enticing positive data from their phase 1 investigator-sponsored trial of INB-100 in Leukemia patients. Their NB-100 treatment has been...
Within’ 1 minute of market open, Magoceuticals Inc. (NASDAQ: MGRX) managed to trade 2x their 5M float. By time of writing, they’ve traded a mind boggling...
Augmedix Inc. experienced a significant surge in its shares, soaring by 60% to $2.88, following the announcement of a strategic financing agreement with HCA Healthcare Inc....
VYNE Therapeutics Inc recently conducted a Phase 1a study on their new drug called VYN201, which could potentially be used to treat a lung condition called...
